3rd Quarter - Report — ALERE INC. for ALERE INC. (2015)

Firm

ALERE INC.

Client

ALERE INC.

Income

—

Expenses

$140,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Transportation TRA

H.R. 22, DRIVE Act- matters related to drug testing. Surface transportation authorization legislation

Lobbyist	Covered position, as disclosed
SETH M RADUS	—

Contacted: Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 22 (114th)

Health Issues HCR

FDA regulation of in-vitro diagnostic testing Importance of diagnostic testing to combat growth in antibiotic resistant bacteria

Lobbyist	Covered position, as disclosed
SETH M RADUS	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Transportation, Dept of (DOT)

Implementation of the laboratory payment provision of the Protecting Access to Medicare Act of 2014, P.L. 113-93 Medicare reimbursement for rapid point-of-care testing Medicare competitive bidding program Medicare coding and fees for drug testing

Lobbyist	Covered position, as disclosed
SETH M RADUS	—

Contacted: Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.

What was lobbied

Transportation TRA

Health Issues HCR

Medicare/Medicaid MMM